{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:11:24Z","timestamp":1789506684896,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013392","name":"Ministere de la Sante et des Services sociaux Quebec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128786","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:02:45Z","timestamp":1780542165000},"page":"128786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["2024\/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada"],"prefix":"10.1016","volume":"88","author":[{"given":"Sara","family":"Carazo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta M.","family":"Skowronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Sauvageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Racine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Brousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128786_bb0005","unstructured":"Comit\u00e9 sur l'immunisation du Qu\u00e9bec. Vaccination contre la COVID-19: Recommandations pour l'automne 2024. https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/3516-vaccination-COVID-19-automne-2024.pdf; 2024 [accessed 1 October 2025]."},{"key":"10.1016\/j.vaccine.2026.128786_bb0010","unstructured":"Comit\u00e9 sur l'immunisation du Qu\u00e9bec. Vaccination contre la COVID-19 et la grippe pour la saison 2025\u20132026. https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/3640-vaccination-covid-19-grippe-saison-2025-2026.pdf; 2025 [accessed 1 October 2025]."},{"key":"10.1016\/j.vaccine.2026.128786_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15585\/mmwr.mm7406a1","article-title":"Interim estimates of 2024\u20132025 COVID-19 vaccine effectiveness among adults aged \u226518 years \u2014 VISION and IVY networks, September 2024\u2013January 2025","volume":"74","author":"Link-Gelles","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128786_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127752","article-title":"Effectiveness of JN.1 monovalent COVID-19 vaccination in EU\/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network study","volume":"64","author":"Humphreys","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128786_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofag019","article-title":"Effectiveness and durability of the BNT162b2 KP.2 vaccine against COVID-19 hospitalization and emergency department or urgent care encounters in US adults","volume":"13","author":"Tartof","year":"2026","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128786_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127870","article-title":"Effectiveness of spring 2024 (XBB.1.5) and autumn 2024 (JN.1) COVID-19 vaccination against hospitalisation in England","volume":"67","author":"Abdul Aziz","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128786_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-67796-0","article-title":"Effectiveness of the 2024\u20132025 KP.2 COVID-19 vaccines in the United States during long-term follow-up","volume":"17","author":"Ioannou","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128786_bb0040","doi-asserted-by":"crossref","unstructured":"Ma KC, Webber A, Lauring AS, et al. Estimated effectiveness of 2024\u20132025 COVID-19 vaccination against severe COVID-19. 2026 JAMA Netw Open 2026; 9:e2557415. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.57415.","DOI":"10.1001\/jamanetworkopen.2025.57415"},{"key":"10.1016\/j.vaccine.2026.128786_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325269","article-title":"Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up","volume":"20","author":"Carazo","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128786_bb0050","unstructured":"Government of Canada. COVID-19 epidemiology update: Testing and variants. https:\/\/health-infobase.canada.ca\/covid-19\/testing-variants.html#a2; 2025 [accessed 1 October 2025]."},{"key":"10.1016\/j.vaccine.2026.128786_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70222","article-title":"Effectiveness of 2024\/25 KP.2 vaccine against outpatient COVID-19 in Canada","volume":"20","author":"Separovic","year":"2026","journal-title":"Influenza Resp Viruses"},{"key":"10.1016\/j.vaccine.2026.128786_bb0060","unstructured":"Institut national de sant\u00e9 publique du Qu\u00e9bec. Donn\u00e9es de vaccination contre la COVID-19 au Qu\u00e9bec. https:\/\/mobile.inspq.qc.ca\/covid-19\/donnees\/vaccination; 2024 [accessed 9 October 2024]."},{"key":"10.1016\/j.vaccine.2026.128786_bb0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(25)00380-9","article-title":"Effectiveness of the BNT162b2 and mRNA-1273 JN.1-adapted vaccines against COVID-19-associated hospitalisation and death: a Danish, nationwide, register-based, cohort study","volume":"25","author":"Hansen","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128786_bb0070","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa2510226","article-title":"Association of 2024\u20132025 Covid-19 vaccine with Covid-19 outcomes in U.S. veterans","volume":"393","author":"Cai","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128786_bb0075","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jamainternmed.2025.5465","article-title":"Durability of 2024-2025 COVID-19 vaccines against JN.1 subvariants","volume":"185","author":"Du","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.vaccine.2026.128786_bb0080","doi-asserted-by":"crossref","unstructured":"Carazo S, Skowronski DM, Brisson M, et al. Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada Lancet Healthy Longev 2023; 4:e409\u201320. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/s2666-7568(23)00099-5.","DOI":"10.1016\/S2666-7568(23)00099-5"},{"key":"10.1016\/j.vaccine.2026.128786_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106177","article-title":"Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study","volume":"89","author":"Kirsebom","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2026.128786_bb0090","unstructured":"Comit\u00e9 sur l'immunisation du Qu\u00e9bec. Administration de doses de rappel du vaccin contre la COVID-19\u00a0: recommandations pour l'hiver et le printemps 2023. https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/3284-doses-rappel-vaccin-covid-19-hiver-printemps-2023.pdf; 2023 [accessed 1 June 2023]."},{"key":"10.1016\/j.vaccine.2026.128786_bb0095","unstructured":"Institut national de sant\u00e9 publique du Qu\u00e9bec. Donn\u00e9es Covid-19 au Qu\u00e9bec. https:\/\/www.inspq.qc.ca\/covid-19\/donnees; 2026 [accessed 15 January 2026]."},{"key":"10.1016\/j.vaccine.2026.128786_bb0100","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1093\/cid\/ciac234","article-title":"Effects of confounding bias in coronavirus disease 2019 (COVID-19) and influenza vaccine effectiveness test-negative designs due to correlated influenza and COVID-19 vaccination Behaviors","volume":"75","author":"Doll","year":"2022","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:38:25Z","timestamp":1789504705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"alternative-id":["S0264410X26005955"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128786","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2024\/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128786"}}